- Home
- DEI vs SWTX Comparison
DEI vs SWTX Comparison
Compare DEI & SWTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DEI
- SWTX
- Stock Information
- Founded
- DEI 1971
- SWTX 2017
- Country
- DEI United States
- SWTX United States
- Employees
- DEI N/A
- SWTX N/A
- Industry
- DEI Real Estate Investment Trusts
- SWTX Biotechnology: Pharmaceutical Preparations
- Sector
- DEI Real Estate
- SWTX Health Care
- Exchange
- DEI Nasdaq
- SWTX Nasdaq
- Market Cap
- DEI 2.8B
- SWTX 3.0B
- IPO Year
- DEI 2006
- SWTX 2019
- Fundamental
- Price
- DEI $13.92
- SWTX $37.57
- Analyst Decision
- DEI Buy
- SWTX Strong Buy
- Analyst Count
- DEI 9
- SWTX 5
- Target Price
- DEI $18.50
- SWTX $72.40
- AVG Volume (30 Days)
- DEI 2.6M
- SWTX 2.0M
- Earning Date
- DEI 05-06-2025
- SWTX 05-01-2025
- Dividend Yield
- DEI 5.46%
- SWTX N/A
- EPS Growth
- DEI N/A
- SWTX N/A
- EPS
- DEI 0.13
- SWTX N/A
- Revenue
- DEI $989,071,000.00
- SWTX $191,589,000.00
- Revenue This Year
- DEI $0.22
- SWTX $85.98
- Revenue Next Year
- DEI N/A
- SWTX $69.16
- P/E Ratio
- DEI $105.20
- SWTX N/A
- Revenue Growth
- DEI 0.46
- SWTX 3417.33
- 52 Week Low
- DEI $12.39
- SWTX $28.21
- 52 Week High
- DEI $20.50
- SWTX $62.00
- Technical
- Relative Strength Index (RSI)
- DEI 38.85
- SWTX 38.39
- Support Level
- DEI $12.39
- SWTX $32.83
- Resistance Level
- DEI $14.50
- SWTX $46.95
- Average True Range (ATR)
- DEI 0.86
- SWTX 3.20
- MACD
- DEI -0.14
- SWTX -0.59
- Stochastic Oscillator
- DEI 35.80
- SWTX 31.51
Stock Price Comparison Chart: DEI vs SWTX
About DEI Douglas Emmett Inc.
Douglas Emmett Inc is a real estate investment trust that acquires, develops, and manages office and multifamily properties in Los Angeles, California and Honolulu, Hawaii in the U.S. The company focuses on owning assets in communities with large supply constraints, such as the affluent neighborhoods of Los Angeles. The vast majority of Douglas Emmett's real estate portfolio is comprised of office buildings in Los Angeles. Most of these assets are located in the areas of Sherman Oaks, Woodland Hills, and Beverly Hills in terms of total square feet. Douglas Emmett derives nearly all of its income in the form of rental revenue from tenants. The vast majority of this also comes from its Los Angeles office buildings. The company's major tenants are legal, financial, and entertainment firms.
About SWTX SpringWorks Therapeutics Inc.
SpringWorks Therapeutics Inc is a clinical stage biopharmaceutical company applying a precision medicine approach to acquiring, developing and commercializing life-changing medicines for underserved patient populations suffering from devastating rare diseases and cancer. The company has a differentiated portfolio of small molecule targeted oncology product candidates and is advancing two potentially registrational clinical trials in rare tumor types, as well as several other programs addressing highly prevalent, genetically defined cancers.